To confirm that TRAIL sensitivity is mediated by DR4, we provided evidence that increasing the expression of DR4 alone in cisplatin-sensitive GC cells enhanced their TRAIL sensitivity and cell apoptosis. This evidence concerns the gene TNFRSF10A and gastric cancer.